Margaret Hills

Prognostic Value of Ki67 Expression After Short-Term Presurgical Endocrine Therapy for Primary Breast Cancer

Mitch Dowsett, Ian E. Smith, S. Ebbs et al. · JNCI Journal of the National Cancer Institute · 2007 · 666 citations · Full text

Medicine, Oncology, Pharmacology +17

Short-Term Changes in Ki-67 during Neoadjuvant Treatment of Primary Breast Cancer with Anastrozole or Tamoxifen Alone or Combined Correlate with Recurrence-Free Survival

Mitch Dowsett, Ian E. Smith, Steve R. Ebbs et al. · Clinical Cancer Research · 2005 · 350 citations · Full text

Medicine, Oncology, Pharmacology +13

A Marker of Homologous Recombination Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Primary Breast Cancer

Monika Graeser, Afshan McCarthy, Christopher J. Lord et al. · Clinical Cancer Research · 2010 · 326 citations · Full text

Medicine, Cancer Biology, Oncology +12

Biomarker Changes During Neoadjuvant Anastrozole, Tamoxifen, or the Combination: Influence of Hormonal Status and HER-2 in Breast Cancer—A Study from the IMPACT Trialists

Mitch Dowsett, Steve R. Ebbs, J. Michael Dixon et al. · Journal of Clinical Oncology · 2005 · 290 citations · Full text

Medicine, Endocrinology, Oncology +16

Correlation between immunohistochemistry (HercepTest) and fluorescence <i>in situ</i> hybridization (FISH) for HER‐2 in 426 breast carcinomas from 37 centres

Mitch Dowsett, J. M. S. Bartlett, Janine Salter et al. · The Journal of Pathology · 2003 · 235 citations

Medicine, Oncology, Pathology +17